Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial
Critical Care2010Vol. 14(2), pp. R38–R38
Citations Over TimeTop 1% of 2010 papers
Pratik P. Pandharipande, Robert D. Sanders, Timothy D. Girard, Stuart McGrane, Jennifer L. Thompson, Ayumi Shintani, Daniel Herr, Mervyn Maze, E. Wesley Ely, the MENDS investigators
Abstract
NCT00095251.
Related Papers
- → Dexmedetomidine: present and future directions(2019)348 cited
- → Dexmedetomidine in Children(2011)268 cited
- → The immunomodulatory mechanism of dexmedetomidine(2021)61 cited
- → Dexmedetomidine hydrochloride as a long-term sedative(2011)20 cited
- Research Progress of Dexmedetomidine Clinical Applications(2013)